- The Washington Times - Friday, March 11, 2011

Federal manipulation of pharmaceutical research companies through the regulatory bottleneck of bureaucracy is a prime example of the dysfunctional nature of government intrusion into our lives ( “Will the FDA let women die?” Web, Opinion, Dec. 10, 2010).

Exhibit A is, perhaps, Richard Pazdur, the director of the Food and Drug Administration’s Office of Oncology Drug Products. He leads the snarl at the private-sector companies trying to improve our lives while doing the unseemly: making a profit.

Having been engaged as a board member at a cancer research foundation for more than 20 years, I marvel at the U.S. pharmaceutical industry’s capacity for creative ingenuity - only to see it repeatedly strangled by the FDA.

The Obama administration falsely claims its desire is to improve relationships with business and encourage pharma research, but all it does - with its disdain for commerce and absolute belief in the good of the nanny state - is to use its power to do the very opposite.

Even before we address the corrupt and destructive nature of Obamacare, a wilful attempt to control our lives and bring to the United States the equivalent of Britain’s bankrupt and inept National Health Service, this administration is strangling the genie.

Onocolgy and related fields operate on the cutting edge of a war with destructive and ravaging diseases. All of us have a stake in this fight. Obstructing creative attempts to salvage people’s lives should take precedent over process. The Obama administration ought to revert to a common-sense partnership with those who have the creative gift to will us all a better existence.

ROBERT F. AGOSTINELLI

Palm Beach, Fla.